摘 要
文章首先简述了全球以及中国医药欧亿·体育（中国）有限公司的发展现状及未来走向，并
分析了中国及全球医药欧亿·体育（中国）有限公司的并购机会及特点。然后文章通过分析云南
沃森生物收购上海泽润、并购河北大安的案例，阐述了中国并购欧亿·体育（中国）有限公司的
现状及存在的挑战。随后文章指出，企业可以通过制定成功的并购战略、
评估和筛选并购对象、监控和管理并购过程这三个阶段实现成功的战略
并购。同时文章认为，影响并购成功的三个重点因素为：并购时机、并
购能力以及并购的人才和方法组合。文章最后得出结论：并购能够成为
中国企业一个成功的增长战略，而中国企业面临的最大障碍是缺乏经验
和技能；正确交易的关键点是建立清晰的与公司目标相符的并购战略，
评估并购目标还需要关注的重点应该是其商业模式和运营效率的可持续
性，有效的合并后整合是并购活动的一个关键。

关键词
：
医药欧亿·体育（中国）有限公司，并购现状，并购战略，成功因素
The strategy, object and transaction of M & A in the
pharmathceutical industry
ABSTRACT
First, the article outlines the status and future trends of global and
China's pharmaceutical industry, and analyzes the M & A opportunities and
characteristics in global pharmaceutical industry and in China. Then, the
article analyzes the acquisition case study between Yunnan Walvax and Zerun,
Hebei Daan, explained the current situation and the challenges of M & A
industry in China. Companies can develop a successful acquisition strategy,
assessment and screening acquisition targets, monitor and manage the
transaction of merger of these three stages to achieve successful goal.
Meanwhile, the impact of M&A for the success of the three key factors: the
timing of acquisitions, the capability of M & A as well as the ability to
approach a combination of talent. Finally, M & A of Chinese enterprises to
become a successful growth strategy, while Chinese enterprises are facing the
biggest gap is the lack of experience and skills; critical point is to establish a
clear target in line with the company's acquisition strategy, evaluating
acquisition targets also need attention should be focused on its business
model and operational efficiency of sustainability, effective post-merger
integration is a key M & A activity.

KEY WORDS
:
PHARMACEUTICAL INDUSTRY, MERGERS AND
ACQUISITIONS, ACQUISITION STRATEGY, SUCCESS FACTORS